Literature DB >> 23861504

Mitral regurgitation: has another magic bullet bitten the dust?

Jeffrey S Borer.   

Abstract

Entities:  

Keywords:  Editorials; disease; mitral valve; pharmacological therapy; ventricular remodeling

Mesh：

Substances：

Year:  2013        PMID： 23861504      PMCID： PMC3739980          DOI： 10.1161/CIRCHEARTFAILURE.113.000409

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  20 in total

Review 1.  Emerging biology of mitral regurgitation: implications for further therapy.

Authors:  Mark R Starling
Journal:  Adv Cardiol       Date:  2002

2.  Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

Authors:  K Chatterjee; W W Parmley; H J Swan; G Berman; J Forrester; H S Marcus
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

3.  Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction.

Authors:  M Nagatsu; F G Spinale; M Koide; H Tagawa; G DeFreitas; G Cooper; B A Carabello
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

4.  Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation.

Authors:  Min Pu; Zhaohui Gao; Daniel K Pu; William R Davidson
Journal:  Circ Heart Fail       Date:  2013-04-11       Impact factor: 8.790

5.  Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.

Authors:  Shintaro Nemoto; Masayoshi Hamawaki; Gilberto De Freitas; Blase A Carabello
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

6.  Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin.

Authors:  L A Mulieri; B J Leavitt; B J Martin; J R Haeberle; N R Alpert
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

7.  Nitroglycerin-induced improvement in exercise tolerance and hemodynamics in patients with chronic rheumatic heart valve disease.

Authors:  J S Borer; D R Redwood; S B Itscoitz; R E Goldstein; S E Epstein
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

8.  Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.

Authors:  H Tsutsui; F G Spinale; M Nagatsu; P G Schmid; K Ishihara; G DeFreyte; G Cooper; B A Carabello
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation.

Authors:  Rajendra H Mehta; Mark A Supiano; Hakan Oral; P Michael Grossman; Daniel S Montgomery; Marla J Smith; Mark R Starling
Journal:  Am Heart J       Date:  2003-06       Impact factor: 4.749

10.  Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction.

Authors:  M R Starling; M M Kirsh; D G Montgomery; M D Gross
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094
View more
  3 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

Review 2.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

3.  Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?

Authors:  Ruchika Meel; Ferande Peters; Elena Libhaber; Mohammed R Essop
Journal:  Cardiovasc J Afr       Date:  2017 Sep/Oct       Impact factor: 1.167
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.